30,000 seniors join 10-Year heart health experiment in rural china

NCT ID NCT07149688

Recruiting now Knowledge-focused Sponsor: Beijing Anzhen Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study will follow 30,000 people aged 60 and older in rural China for up to 10 years. Researchers want to see if a comprehensive program—including medication, lifestyle changes, health education, and regular check-ups with a 7-day heart monitor—can lower the number of heart attacks, strokes, and deaths from heart disease. The goal is to find a practical way to manage chronic heart conditions in village communities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could show that a simple, community-based program of medication, lifestyle advice, and monitoring can greatly reduce heart problems in older adults.
What could go wrong: This is an observational study, not a controlled trial, so results may be influenced by other factors. It is also limited to one region in China, so findings may not apply elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation coronary artery disorder Coronary Disease heart failure hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION (AF) CORONARY HEART DISEASE (CHD) HEART FAILURE HYPERTENSION

Contacts and locations

Locations

Beijing Anzhen Hospital
RECRUITING

Beijing, Beijing Municipality, 100029, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.